Drug Patent Reports
Showing 181–192 of 585 results
- Drug Patent Reports
GENVOYA (cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
GIAPREZA (angiotensin ii acetate) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
GILOTRIF (afatinib dimaleate) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
GIVLAARI (givosiran sodium) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
GLEOLAN (aminolevulinic acid hydrochloride) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
GLYXAMBI (empagliflozin; linagliptin) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
GOPRELTO (cocaine hydrochloride) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
HALAVEN (eribulin mesylate) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
HARVONI (ledipasvir; sofosbuvir) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
HORIZANT (gabapentin enacarbil) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
IBRANCE (palbociclib) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now - Drug Patent Reports
IBSRELA (tenapanor hydrochloride) Drug Profile, 2024
Original price was: $1,199.00.$699.00Current price is: $699.00. Add to cart Buy Now
